Privacy Policy
You're receiving this email because you've opted in to receive information about LensCrafters products and services. If you do not wish to receive emails like this in the future, please unsubscribe.
|
†Wolffsohn JS, et al. IMI–myopia control reports overview and introduction. Investigative ophthalmology & visual science. 2019 Feb 28;60(3):M1-9.
‡Sankaridurg P. A less myopic future: what are the prospects? Clin Exp Optom. 2015;98(6):494-6.
§Only available with Essilor® Stellest® Lenses.
¶Flitcroft, D.I., He, M., Jonas, J.B., Jong, M., Naidoo, K., Ohno-Matsui, K., Rahi, J., Resnikoff, S., Vitale, S., & Yannuzzi, L. (2019, February 28). IMI – Defining and classifying myopia: a proposed set of standards for clinical and epidemiologic studies. Investigative Ophthalmology & Visual Science. 60(3):M20-30.
#Compared to single vision lenses. Results from a prospective, randomized, double-masked, multicenter U.S. clinical trial in myopic children aged 6-12 years at initiation of treatment.
††Essilor International, data on file (2025).
Essilor International - August 2026 - Essilor®️ and Stellest®️ are trademarks of Essilor International.
*Ask associate for details or find a store to learn more
**Applies to original purchase. Does not cover accidental damage, scratches, breakage or theft.
|
THIS EMAIL IS AN ADVERTISEMENT.
© 2026 LensCrafters. All rights reserved. LensCrafters • 4000 Luxottica Place • Mason, Ohio 45040 • 1-877-753-6727
|
|